1. Japan's PMDA issues precautions update for aminolevulinic acid hydrochloride

   News item 29 January 2022 Pages: 1 - 1

2. Ad26.COV2.S COVID-19 vaccine: TTS a rare, but serious adverse event

   Clinical study 29 January 2022 Pages: 2 - 2

3. Adding neprilysin inhibitors to ACE inhibitors or ARBs does not increase renal adverse events

   Clinical study 29 January 2022 Pages: 3 - 3

4. Aflibercept versus ranibizumab: similar risk of stroke, MI and death

   Clinical study 29 January 2022 Pages: 4 - 4

5. Antidepressant-related ADRs common in patients with MDD

   Clinical study 29 January 2022 Pages: 5 - 5

6. Drug-related fatal events in Korea: analysis of cases reported to the national pharmacovigilance database

   Clinical study 29 January 2022 Pages: 6 - 6

7. Link between short-term beta-blocker use and depression

   Clinical study 29 January 2022 Pages: 7 - 7

8. Many oxycodone-related deaths linked to pharmacodynamically-interacting drugs in Sweden

   Clinical study 29 January 2022 Pages: 8 - 8

9. Metformin does not increase cardiovascular events in patients with CVD

   Clinical study 29 January 2022 Pages: 9 - 9

10. Reported rates of CVST due to COVID-19 vaccination rose after publicising these ADRs

    Clinical study 29 January 2022 Pages: 10 - 10

11. Risk of spontaneous abortion with adefovir dipivoxil or entecavir

    Clinical study 29 January 2022 Pages: 11 - 11

12. Semaglutide and liraglutide have differing gastrointestinal ADR profiles

    Clinical study 29 January 2022 Pages: 12 - 12

13. Other adverse reaction research

    News item 29 January 2022 Pages: 13 - 13

14. Ad26.COV2-S

    Case report 29 January 2022 Pages: 14 - 14

15. Afatinib

    Case report 29 January 2022 Pages: 15 - 15

16. Alectinib

    Case report 29 January 2022 Pages: 16 - 16

17. Alectinib/ceritinib/crizotinib

    Case report 29 January 2022 Pages: 17 - 17

18. Amiodarone

    Case report 29 January 2022 Pages: 18 - 18

19. Amoxicillin/clavulanic-acid

    Case report 29 January 2022 Pages: 19 - 19

20. Amphotericin-B

    Case report 29 January 2022 Pages: 20 - 20

21. Amphotericin-B

    Case report 29 January 2022 Pages: 21 - 21

22. Amphotericin-B-liposomal

    Case report 29 January 2022 Pages: 22 - 22

23. Amphotericin-B-liposomal/meglumine-antimonate

    Case report 29 January 2022 Pages: 23 - 23

24. Anakinra/apixaban/prednisone

    Case report 29 January 2022 Pages: 24 - 24

25. Anti-inflammatories

    Case report 29 January 2022 Pages: 25 - 25

26. Antibacterials

    Case report 29 January 2022 Pages: 26 - 26

27. Antibacterials/phenytoin

    Case report 29 January 2022 Pages: 27 - 27

28. Anticoagulants/Azd-1222/immune-globulin

    Case report 29 January 2022 Pages: 28 - 28

29. Antiepileptic-drugs

    Case report 29 January 2022 Pages: 29 - 29

30. Antihyperlipidaemics/Antineoplastics/Secosteroids

    Case report 29 January 2022 Pages: 30 - 30

31. Antineoplastics

    Case report 29 January 2022 Pages: 31 - 31

32. Antineoplastics

    Case report 29 January 2022 Pages: 32 - 32

33. Antineoplastics

    Case report 29 January 2022 Pages: 33 - 33

34. Antineoplastics

    Case report 29 January 2022 Pages: 34 - 34

35. Antineoplastics

    Case report 29 January 2022 Pages: 35 - 35

36. Antineoplastics

    Case report 29 January 2022 Pages: 36 - 36

37. Antineoplastics

    Case report 29 January 2022 Pages: 37 - 37

38. Antineoplastics

    Case report 29 January 2022 Pages: 38 - 38

39. Antineoplastics

    Case report 29 January 2022 Pages: 39 - 39

40. Antineoplastics

    Case report 29 January 2022 Pages: 40 - 40

41. Antineoplastics

    Case report 29 January 2022 Pages: 41 - 41

42. Antineoplastics/dexamethasone

    Case report 29 January 2022 Pages: 42 - 42

43. Antineoplastics/epirubicin

    Case report 29 January 2022 Pages: 43 - 43

44. Antineoplastics/immunosuppressannts

    Case report 29 January 2022 Pages: 44 - 44

45. Antineoplastics/pegfilgrastim

    Case report 29 January 2022 Pages: 45 - 45

46. Antineoplastics\antifibrotics

    Case report 29 January 2022 Pages: 46 - 46

47. Antiplatelets/dabigatran-etexilate

    Case report 29 January 2022 Pages: 47 - 47

48. Antipsoriatics

    Case report 29 January 2022 Pages: 48 - 48

49. Antiretrovirals

    Case report 29 January 2022 Pages: 49 - 49

50. Antivenins

    Case report 29 January 2022 Pages: 50 - 50